Clinical Trial Update: Docetaxel, Cetuximab and Cisplatin Followed by Radiation, Cetuximab and Cisplatin in Head and Neck Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating docetaxel, cetuximab, and cisplatin followed by radiation with continued cetuximab/cisplatin in head and neck cancer has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Cetuximab (cetuximab)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: University of Pittsburgh | Conditions: Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-07-11